Can Clinically Significant Prostate Cancer Be Detected with Multiparametric …

Artículos que citan Can Clinically Significant Prostate Cancer Be Detected with Multiparametric …

Título / Autor	Año
EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent N Mottet, J Bellmunt, M Bolla, E Briers, MG Cumberbatch, M De Santis, ... European urology 71 (4), 618-629	2017
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study HU Ahmed, AES Bosaily, LC Brown, R Gabe, R Kaplan, MK Parmar, ... The Lancet 389 (10071), 815-822	2017
Synopsis of the PI-RADS v2 guidelines for multiparametric prostate magnetic resonance imaging and recommendations for use JO Barentsz, JC Weinreb, S Verma, HC Thoeny, CM Tempany, F Shtern, ... European urology 69 (1), 41	2016
Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study H Grönberg, J Adolfsson, M Aly, T Nordström, P Wiklund, Y Brandberg, ... The lancet oncology 16 (16), 1667-1676	2015
Active surveillance for prostate cancer: current evidence and contemporary state of practice JJ Tosoian, HB Carter, A Lepor, S Loeb Nature Reviews Urology 13 (4), 205	2016
Prebiopsy multiparametric magnetic resonance imaging for prostate cancer diagnosis in biopsy-naive men with suspected prostate cancer based on elevated prostate-specific antigen values: results from a randomized prospective blinded controlled trial PP Tonttila, J Lantto, E Pääkkö, U Piippo, S Kauppila, E Lammentausta, ... European urology 69 (3), 419-425	2016
New and established technology in focal ablation of the prostate: a systematic review M Valerio, Y Cerantola, SE Eggener, H Lepor, TJ Polascik, A Villers, ... European urology 71 (1), 17-34	2017
Diagnostic pathway with multiparametric magnetic resonance imaging versus standard pathway: results from a randomized prospective study in biopsy-naive patients with suspected prostate cancer F Porpiglia, M Manfredi, F Mele, M Cossu, E Bollito, A Veltri, S Cirillo, ... European urology 72 (2), 282-288	2017
Prostate cancer: PI-RADS version 2 helps preoperatively predict clinically significant cancers SY Park, DC Jung, YT Oh, NH Cho, YD Choi, KH Rha, SJ Hong, K Han Radiology 280 (1), 108-116	2016
Multiparametric prostate magnetic resonance imaging in the evaluation of prostate cancer B Turkbey, AM Brown, S Sankineni, BJ Wood, PA Pinto, PL Choyke CA: a cancer journal for clinicians 66 (4), 326-336	2016
Optimising the diagnosis of prostate cancer in the era of multiparametric magnetic resonance imaging: a cost-effectiveness analysis based on the Prostate MR Imaging Study (PROMIS) R Faria, MO Soares, E Spackman, HU Ahmed, LC Brown, R Kaplan, ... European urology 73 (1), 23-30	2018
The diagnostic performance of multiparametric magnetic resonance imaging to detect significant prostate cancer JE Thompson, PJ Van Leeuwen, D Moses, R Shnier, P Brenner, ... The Journal of urology 195 (5), 1428-1435	2016
Abbreviated biparametric prostate MR imaging in men with elevated prostate-specific antigen CK Kuhl, R Bruhn, N Krämer, S Nebelung, A Heidenreich, S Schrading Radiology 285 (2), 493-505	2017
Magnetic resonance imaging targeted biopsy improves selection of patients considered for active surveillance for clinically low risk prostate cancer based on systematic biopsies A Ouzzane, R Renard-Penna, F Marliere, P Mozer, J Olivier, J Barkatz, ... The Journal of urology 194 (2), 350-356	2015
Role of magnetic resonance imaging in prostate cancer screening: a pilot study within the Göteborg randomised screening trial AG Bergdahl, U Wilderäng, G Aus, S Carlsson, JE Damber, M Frånlund, ... European urology 70 (4), 566-573	2016
Multiparametric magnetic resonance imaging in prostate cancer management: current status and future perspectives TWJ Scheenen, AB Rosenkrantz, MA Haider, JJ Fütterer Investigative radiology 50 (9), 594-600	2015
Results of targeted biopsy in men with magnetic resonance imaging lesions classified equivocal, likely or highly likely to be clinically significant prostate cancer W Venderink, A van Luijtelaar, JGR Bomers, M van der Leest, ... European urology 73 (3), 353-360	2018
The value of magnetic resonance imaging and ultrasonography (MRI/US)‐fusion biopsy platforms in prostate cancer detection: a systematic review M Gayet, A van der Aa, HP Beerlage, BP Schrier, PFA Mulders, H Wijkstra BJU international 117 (3), 392-400	2016
Why and where do we miss significant prostate cancer with multi-parametric magnetic resonance imaging followed by magnetic resonance-guided and transrectal ultrasound-guided biopsy in biopsy-naïve men? MG Schouten, M van der Leest, M Pokorny, M Hoogenboom, JO Barentsz, ... European urology 71 (6), 896-903	2017
The PICTURE study: diagnostic accuracy of multiparametric MRI in men requiring a repeat prostate biopsy LAM Simmons, A Kanthabalan, M Arya, T Briggs, D Barratt, SC Charman, ... British journal of cancer 116 (9), 1159	2017

1 - 20

Las fechas y los recuentos de citas son estimados y se determinan de forma automática mediante un programa informático.